Medicare Enrolled
Dr. Mohamadali Amlani, M.D.
Optician · Flint, MI
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amlani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amlani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amlani
Dr. Mohamadali Amlani is an optician specialist in Flint, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amlani performed 2,979 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Amlani received a total of $7,507 from 37 pharmaceutical and/or device companies across 397 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amlani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 12% volume in MI
$7,507 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,979
Medicare services
Top 12% in MI for optician
Not available
Unique patients (not deduplicated)
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $88 | $160 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
291 | $53 | $400 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
274 | $18 | $100 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
217 | $126 | $403 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
200 | $10 | $40 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
180 | $45 | $200 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
168 | $14 | $75 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
146 | $87 | $200 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
122 | $20 | $100 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
94 | $19 | $100 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
78 | $19 | $45 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
78 | $51 | $150 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
74 | $46 | $200 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
74 | $607 | $1,200 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
73 | $314 | $1,250 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
57 | $32 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
55 | $59 | $130 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
48 | $23 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $118 | $240 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
29 | $68 | $160 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $100 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.2% high complexity
15.9% medium
61.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,507
Total received (2018-2024)
Avg $1,072/year across 7 years
Top 13% in MI for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
397
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,277
2023
$1,281
2022
$1,192
2021
$1,213
2020
$475
2019
$1,417
2018
$651
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$313
Amgen Inc.
$177
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Vital Connect, Inc
$122
Merck Sharp & Dohme LLC
$87
PFIZER INC.
$84
Boston Scientific Corporation
$54
Kestra Medical Technology Services, Inc.
$48
E.R. Squibb & Sons, L.L.C.
$47
SANOFI-AVENTIS U.S. LLC
$37
Lexicon Pharmaceuticals, Inc.
$36
Janssen Pharmaceuticals, Inc
$30
Kiniksa Pharmaceuticals International, plc
$29
Abbott Laboratories
$21
Philips North America LLC
$19
Esperion Therapeutics, Inc.
$19
Top 3 companies account for 50.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,472
Novartis Pharmaceuticals Corporation
$1,026
Janssen Pharmaceuticals, Inc
$589
E.R. Squibb & Sons, L.L.C.
$490
SANOFI-AVENTIS U.S. LLC
$443
PFIZER INC.
$332
Merck Sharp & Dohme LLC
$305
Actelion Pharmaceuticals US, Inc.
$276
Astellas Pharma US Inc
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$260
Medtronic Vascular, Inc.
$231
NOVARTIS PHARMACEUTICALS CORPORATION
$174
Abbott Laboratories
$162
Merck Sharp & Dohme Corporation
$155
Regeneron Healthcare Solutions, Inc.
$148
Kestra Medical Technology Services, Inc.
$141
Boston Scientific Corporation
$133
Esperion Therapeutics, Inc.
$127
Vital Connect, Inc
$122
Kiniksa Pharmaceuticals, Ltd.
$109
HeartFlow, Inc.
$94
Alnylam Pharmaceuticals Inc.
$65
Bayer HealthCare Pharmaceuticals Inc.
$61
Bayer Healthcare Pharmaceuticals Inc.
$50
Lexicon Pharmaceuticals, Inc.
$50
Kiniksa Pharmaceuticals International, plc
$29
CARDIVA MEDICAL, INC.
$26
BOSTON SCIENTIFIC CORPORATION
$26
Philips Electronics North America Corporation
$20
AstraZeneca Pharmaceuticals LP
$20
Philips North America LLC
$19
Teleflex LLC
$19
Medtronic, Inc.
$16
BIOTRONIK INC.
$15
Lundbeck LLC
$14
GENZYME CORPORATION
$14
Novo Nordisk Inc
$13
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
(CK4) MCOT · Aimovig · Amplia MRI · Arcalyst · Assure WCD · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CardioMEMS HF System · Confirm Rx · CoreValve Evolut · Corlanor · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · ENTRESTO · EVKEEZA · FABRAZYME · FFRct · GALLANT · GENERAL THERAPIES · General - Therapies · GlideLight · HeartMate 3 Left Ventricular Assist Device · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LOKELMA · MANTA · MULTAQ · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · Rybelsus · SQ-RX PULSE GENERATOR · UPTRAVI · VERQUVO · VITALPATCH RTM · VYNDAQEL · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
59
County median income
$60,673
Nearest hospital to ZIP centroid (approximate)
MCLAREN FLINT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amlani is a remote & electrophysiology specialist, with above-average Medicare volume (top 12% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amlani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amlani performed 664 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Amlani receive payments from pharmaceutical companies?
Yes. Dr. Amlani received a total of $7,507 from 37 companies across 397 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amlani's costs compare to other opticians in Flint?
Dr. Amlani's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amlani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Flint
Browse opticians in Flint ranked by procedure volume and transparency data.
Highest volume
Top Opticians in MI
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in MI
Which MI opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology